PGY2 Banner University Tucson Oncology Specialty Residency

The PGY2 Oncology Pharmacy Residency Program at Banner - University Medical Center Tucson/University of Arizona Cancer Center is a 12-month program for residents with an interest in oncology, hematology, stem cell transplant, and investigational drug research. The program was established in 2017 and is accredited by the American Society of Health-System Pharmacists (ASHP).

The PGY2 Oncology Pharmacy Residency builds upon the foundations of practice acquired during Doctor of Pharmacy education and the PGY1 pharmacy residency to provide a well-rounded experience in acute and ambulatory medical oncology, hematology, and stem cell transplant. The University of Arizona Cancer Center is the only NCI-designated Comprehensive Cancer Center headquartered in the state of Arizona, where bringing promising new therapies from the laboratory to the bedside is a high priority. The PGY2 oncology resident will serve as a fully integrated member of multidisciplinary teams involved in the therapeutic decision-making process and optimizing clinical outcomes for patients with cancer. In addition, the resident will be exposed to a broad spectrum of new diagnostic, prevention and treatment strategies, and gain experiences in clinical research, quality improvement, teaching, and precepting. The residency is designed to prepare the resident for future clinical, research, or academic positions, and board certification in oncology pharmacy.

  • National Matching Services Code: 81054
  • Duration/Type: 12-month residency
  • Number of positions: One
  • Salary: $52,000
  • Application deadline: January 5
  • How to Apply

Patient Care Learning Experiences

Required Rotations

  • Oncology Pharmacy Orientation
  • Breast Cancer, Outpatient
  • Gastrointestinal Malignancies, Outpatient
  • Head, Neck, and Thoracic Oncology, Outpatient
  • Hematologic Malignancies, Outpatient
  • Melanoma and Sarcoma, Outpatient
  • Genitourinary Oncology, Outpatient
  • Gynecologic Oncology, Outpatient
  • Adult Hematology and Oncology, Inpatient
  • Leukemia and Hematopoietic Stem Cell Transplant (HSCT), Inpatient
  • Early Phase Clinical Trials, Outpatient
  • Investigational Drug Services
  • Specialty Pharmacy

Elective Rotations (Select 2)

Two rotations are chosen as electives based on resident preference. They may choose to repeat rotations from prior experiences or choose from the following elective offerings:

  • Adult Oncology Palliative Care
  • Pediatric Hematology, Oncology, and BMT

Longitudinal:

  • Oncology Administrative Forum
  • Oncology Chemotherapy Operations
  • Pharmacy Residency Project

Our program participates in the American Society of Health-System Pharmacists (ASHP) Residency Matching Program and is fully accredited by ASHP.

Pharmacy Residency Director

Lisa E. Davis, PharmD, FCCP, BCPS, BCOP
(520) 626-5625

Residency Clinical Coordinator

Jerrelee Hollings, PharmD
(520) 694-0350